The global infusion pumps market size was estimated to be USD 17.22 billion in 2023 and is expected to reach USD 37.61 billion by 2034 with a CAGR of 7.36% during the forecast period 2024-2034. The market will develop as a result of factors such as the growing prevalence of chronic diseases, technological advancements, the rise in ambulatory care and home healthcare, an increase in surgical procedures, government initiatives and healthcare policies, and an increased emphasis on patient-centered care.
The need for infusion pumps is being driven by the increase in chronic illness incidence, which includes diabetes, cancer, and cardiovascular disorders. Insulin, chemotherapeutic treatments, and other vital therapies require the use of these devices to provide medication. For instance, in October 2023, Medtronic plc introduced the MiniMed 780G, a next-generation insulin pump with enhanced automated insulin administration and safety features, using SmartGuard technology.
By product, the syringe infusion pumps segment accounted for the highest revenue-grossing segment in the global infusion pumps market in 2023 owing to the increasing adoption of precision drug delivery systems, a surge in demand for ambulatory and home healthcare solutions, and the ability of syringe infusion pumps to provide accurate and controlled administration of medications, particularly in critical care settings. For instance, in December 2023, B. Braun Melsungen AG and Roche Diabetes Care announced a collaboration to co-market B. Braun's SpacePump infusion pumps alongside Roche's Accu-Chek Guide blood glucose monitoring system. Additionally, the insulin pump segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing global prevalence of diabetes, a growing awareness of the benefits of continuous subcutaneous insulin infusion (CSII) therapy, and advancements in insulin pump technologies.
By therapy, the chemotherapy/oncology segment accounted for the highest revenue-grossing segment in the global infusion pumps market in 2023 owing to the escalating prevalence of cancer worldwide, the increasing number of chemotherapy treatments, and the critical need for precise and controlled drug administration. For instance, in January 2024, Becton, Dickinson and Company announced that they had acquired the vascular access division of C. R. Bard, therefore enhancing their offering in infusion treatment. Additionally, the pain management segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing global burden of chronic pain conditions, a rising awareness of the importance of effective pain control, and the expanding application of infusion pumps for delivering analgesic medications.
By end-user, the hospitals segment accounted for the highest revenue-grossing segment in the global infusion pumps market in 2023 owing to the pivotal role of infusion pumps in various medical treatments conducted within hospital settings. For instance, in October 2023, Humac GmbH, a top German provider of home care services, including infusion treatment, was successfully acquired by Fresenius SE & Co. KGaA. Additionally, the home care segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend toward patient-centric care, a growing aging population, and advancements in portable and user-friendly infusion pump technologies that enable safe and effective treatments in home settings.
North American region is anticipated to have the highest revenue share during the forecast period owing to the well-established healthcare infrastructure, increasing prevalence of chronic diseases, a high level of awareness regarding advanced medical technologies, and favorable reimbursement policies. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing healthcare expenditure, rising prevalence of chronic diseases, expanding access to healthcare facilities, and a growing awareness of advanced medical technologies. For instance, in June 2023, Smiths Medical, Inc. acquired Trudell Medical, a producer of specialty infusion pumps for infants, to broaden the scope of neonatal care services.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
The need for infusion pumps is being driven by the increase in chronic illness incidence, which includes diabetes, cancer, and cardiovascular disorders. Insulin, chemotherapeutic treatments, and other vital therapies require the use of these devices to provide medication. For instance, in October 2023, Medtronic plc introduced the MiniMed 780G, a next-generation insulin pump with enhanced automated insulin administration and safety features, using SmartGuard technology.
By product, the syringe infusion pumps segment accounted for the highest revenue-grossing segment in the global infusion pumps market in 2023 owing to the increasing adoption of precision drug delivery systems, a surge in demand for ambulatory and home healthcare solutions, and the ability of syringe infusion pumps to provide accurate and controlled administration of medications, particularly in critical care settings. For instance, in December 2023, B. Braun Melsungen AG and Roche Diabetes Care announced a collaboration to co-market B. Braun's SpacePump infusion pumps alongside Roche's Accu-Chek Guide blood glucose monitoring system. Additionally, the insulin pump segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing global prevalence of diabetes, a growing awareness of the benefits of continuous subcutaneous insulin infusion (CSII) therapy, and advancements in insulin pump technologies.
By therapy, the chemotherapy/oncology segment accounted for the highest revenue-grossing segment in the global infusion pumps market in 2023 owing to the escalating prevalence of cancer worldwide, the increasing number of chemotherapy treatments, and the critical need for precise and controlled drug administration. For instance, in January 2024, Becton, Dickinson and Company announced that they had acquired the vascular access division of C. R. Bard, therefore enhancing their offering in infusion treatment. Additionally, the pain management segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing global burden of chronic pain conditions, a rising awareness of the importance of effective pain control, and the expanding application of infusion pumps for delivering analgesic medications.
By end-user, the hospitals segment accounted for the highest revenue-grossing segment in the global infusion pumps market in 2023 owing to the pivotal role of infusion pumps in various medical treatments conducted within hospital settings. For instance, in October 2023, Humac GmbH, a top German provider of home care services, including infusion treatment, was successfully acquired by Fresenius SE & Co. KGaA. Additionally, the home care segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend toward patient-centric care, a growing aging population, and advancements in portable and user-friendly infusion pump technologies that enable safe and effective treatments in home settings.
North American region is anticipated to have the highest revenue share during the forecast period owing to the well-established healthcare infrastructure, increasing prevalence of chronic diseases, a high level of awareness regarding advanced medical technologies, and favorable reimbursement policies. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing healthcare expenditure, rising prevalence of chronic diseases, expanding access to healthcare facilities, and a growing awareness of advanced medical technologies. For instance, in June 2023, Smiths Medical, Inc. acquired Trudell Medical, a producer of specialty infusion pumps for infants, to broaden the scope of neonatal care services.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product, Therapy, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement.
Segmentation: Infusion Pumps Market Report 2023 - 2034
Infusion Pumps Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Large Volume Infusion Pumps
- Syringe Infusion Pumps
- Insulin Pumps
- Enteral Feeding Pumps
- Elastomeric Pumps
- Implantable Pumps
Infusion Pumps Market Analysis & Forecast by Therapy 2023 - 2034 (Revenue USD Bn)
- Chemotherapy/Oncology
- Diabetes
- Pain Management
- Gastrointestinal Diseases
- Pediatrics
Infusion Pumps Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Ambulatory Surgical Centers
- Home Care
Infusion Pumps Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Infusion Pumps Market: Product Estimates & Trend Analysis
8. Infusion Pumps Market: Therapy Estimates & Trend Analysis
9. Infusion Pumps Market: End-User Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Infusion Pumps Market
12. Europe Global Infusion Pumps Market
13. Asia Pacific Global Infusion Pumps Market
14. Latin America Global Infusion Pumps Market
15. MEA Global Infusion Pumps Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Medtronic plc
- B. Braun Melsungen AG
- Becton
- Dickinson and Company (BD)
- Fresenius SE & Co. KGaA
- Smiths Medical Inc.
- Baxter International Inc.
- Hospira (now part of Pfizer Inc.)
- Terumo Corporation
- Johnson & Johnson
- Roche Diagnostics
- ICU Medical Inc.
- CME Medical (a BD company)
- Tandem Diabetes Care Inc.
- Animas Corporation
- Insulet Corporation.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 17.22 Billion |
| Forecasted Market Value ( USD | $ 37.61 Billion |
| Compound Annual Growth Rate | 7.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
